The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • sartalon@lemmy.world
    6·
    1 day ago

    I only want to disagree about Facebook not monetizing private data in 2008.

    My wife was in politics/campaign management. They were already selling fairly sophisticated targeted ads by then.

    I was shocked/terrified by how well they were targeting and it wasn’t even close to what they have today.

    FUCK CORPORATIONS.

    • pemptago@lemmy.mlEnglish
      3·
      1 day ago

      You’re right. My mistake. I was going off memory and 2009 came to mind, but now that you mention it I do remember hearing about tech for the 2008 election- but I heard that years later, after cambridge analytica. All’s to say, it was emerging around that time and it wasn’t a big, public announcement. People around the epicenter knew but most were in the dark. I know i was, till the mid 2010’s. Since then I have 0 trust in big tech/most corporations, but I’ve definitely made my share of mistakes and wish there were more protections/public education.